Consistent with the crucial pathogenetic role of tau in AD, NGF has been demonstrated to regulate the steady-state levels [135] and the post-translational modification of tau, including phosphorylation, cleavage, and ubiquitination [136,137,138,139,140]. This evidence concerns the gene MAPT and Alzheimer disease.